Clinical Trials
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
- Heart/Cardiovascular
Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial (CHASM CS- RCT)
- Ages18 years and older
- GenderBoth
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth